In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery

The development of clinically acceptable albumin-based nanoparticle formulations for use in pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials in the lungs combined with a lack of information on albumin nanoparticle clearance kinetics and biodistribution. In th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Control Release
Autors principals: Woods, A., Patel, A., Spina, D., Riffo-Vasquez, Y., Babin-Morgan, A., de Rosales, R.T.M., Sunassee, K., Clark, S., Collins, H., Bruce, K., Dailey, L.A., Forbes, B.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Science Publishers 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674532/
https://ncbi.nlm.nih.gov/pubmed/25980621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.05.269
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars